Clinical Trial Update: Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating subcutaneous pasireotide in patients with post-bariatric hypoglycemia, sponsored by RECORDATI GROU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-bariatric Hypoglycemia

Drugs mentioned

• Pasireotide (pasireotide)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Post-Bariatric Hypoglycemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING